Development and aging of the cerebrum: assessment with proton MR spectroscopy.

BACKGROUND AND PURPOSE MR spectroscopy allows the noninvasive evaluation of in vivo brain metabolites. Our purpose was to use this technique to assess metabolic alterations in the human cerebrum during growth, maturation, and aging. METHODS Ninety normal human brains in subjects aged 4 to 88 years were examined with multivoxel proton MR spectroscopy. Spectra were obtained from specific voxels of 2.5 cm3 in the gray and white matter of the centrum semiovale. The ratios of N-acetylaspartate (NAA) to choline (Cho) were calculated to describe age-dependent alterations in cerebral metabolites. RESULTS White matter NAA/Cho ratios showed rapid growth during the first decade and reached a maximum value in the second or early third decade, followed by a steady decline starting in the latter half of the third decade. The maximum peak ages for NAA/Cho were 21.9, 17.6, and 15.9 years (mean, 18.5 years) for the anterior, middle, and posterior white matter, respectively. A significant cerebral laterality of the white matter NAA/Cho was found in male subjects during development. The growth spurt and age-related decline of the white matter NAA/Cho were steeper in male than in female subjects. In contrast, the gray matter NAA/Cho showed a gradual decline with age. CONCLUSION Proton MR spectroscopy shows significant regional and sex differences in the level of cerebral metabolites during the process of growth, maturation, and aging. This technique may play an important role in clinical applications for various conditions of metabolic disorders of the human brain.

[1]  J. Dobbing,et al.  Quantitative growth and development of human brain , 1973, Archives of disease in childhood.

[2]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[3]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[4]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[5]  D. Kimura Sex differences in the brain. , 1992, Scientific American.

[6]  P. Barnes,et al.  Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. , 1997, AJNR. American journal of neuroradiology.

[7]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research. , 1985, Archives of neurology.

[8]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[9]  B J Soher,et al.  Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference , 1996, Magnetic resonance in medicine.

[10]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[11]  S. Pavlakis,et al.  Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. , 1996, Radiology.

[12]  R. Gorski,et al.  Sex differences in the corpus callosum of the living human being , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  D. Jenden,et al.  The source of choline for acetylcholine synthesis in brain. , 1976, Life sciences.

[14]  G. Holmes Morphological and Physiological Maturation of the Brain in the Neonate and Young Child , 1986, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[15]  H. Larsson,et al.  The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.

[16]  P. Yakovlev,et al.  The myelogenetic cycles of regional maturation of the brain , 1967 .

[17]  C. McArdle,et al.  Developmental features of the neonatal brain: MR imaging. Part I. Gray-white matter differentiation and myelination. , 1987, Radiology.

[18]  B. Hart,et al.  Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. , 1998, Radiology.

[19]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[20]  M. Castillo,et al.  Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[21]  A. Minkowski,et al.  Regional Development of the Brain in Early Life , 1968 .

[22]  L. Hayflick The cell biology of human aging. , 1980, Scientific American.

[23]  Der,et al.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.

[24]  K. Houkin,et al.  Cerebral metabolic changes in delayed carbon monoxide sequelae studied by proton MR spectroscopy , 2004, Neuroradiology.

[25]  W M Brooks,et al.  Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. , 1997, AJNR. American journal of neuroradiology.

[26]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[27]  K. Lim,et al.  Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.

[28]  T. Matsuda,et al.  Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. , 1995, Radiology.

[29]  K. Krishnan,et al.  Proton spectroscopy of human brain: Effects of age and sex , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  D. Selkoe,et al.  Aging brain, aging mind. , 1992, Scientific American.

[31]  K. Yamashita,et al.  Development and aging of brain midline structures: assessment with MR imaging. , 1989, Radiology.

[32]  R. Holloway,,et al.  Sexual dimorphism in the human corpus callosum. , 1982, Science.

[33]  G. Fein,et al.  Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. , 1996, Archives of neurology.

[34]  D J Jenden,et al.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.

[35]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: II. A hypothesis and a program for research. , 1985, Archives of neurology.

[36]  W. Grodd,et al.  In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy , 1990, The Lancet.

[37]  W. Grodd,et al.  Localized 1H in vivo NMR spectroscopy of small‐volume elements in human brain at 1.5 T , 1990, Magnetic resonance in medicine.

[38]  C. McArdle,et al.  Developmental features of the neonatal brain: MR imaging. Part II. Ventricular size and extracerebral space. , 1987, Radiology.

[39]  A. Bizzi,et al.  Cerebral White Matter in the Centrum Semiovale Exhibits a Larger N‐acetyl Signal than Does Gray Matter in Long Echo Time 1H‐Magnetic Resonance Spectroscopic Imaging , 1995, Magnetic resonance in medicine.

[40]  A J Barkovich,et al.  Normal postnatal development of the corpus callosum as demonstrated by MR imaging. , 1988, AJNR. American journal of neuroradiology.

[41]  T. H. Newton,et al.  MRI of normal brain maturation. , 1986, AJNR. American journal of neuroradiology.